BrightSpring Health Services, Inc. Common Stock
BTSGNASDAQHealthcare● Active
$57.40
+$0.00(+0.00%)
Market Cap$11.1B
P/E Ratio—
52W High$62.11
52W Low$19.01
BrightSpring Health Services, Inc. Common Stock (BTSG) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
BTSG · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 1, 2026EPS Actual
$0.39
Est. $0.29 · +34.5%
Revenue
$3.61B
Est. $3.39B · +6.6%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 1, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue✓ 1-Quarter EPS Beat Streak
BTSG reports quarterly as a NASDAQ-listed Medical - Healthcare Information Services company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.84B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.84B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 31, 2026 | $0.35 | — | — | — | $3.67B | — |
| ▲ Q2 FY2026 | May 1, 2026 | $0.29 | $0.39 | +34.5% | $3.61B | $3.39B | +6.6% |
| ▼ Q1 FY2026 | Feb 27, 2026 | $0.34 | $0.33 | -2.9% | $3.55B | $3.38B | +5.0% |
| ▲ Q4 FY2025 | Oct 31, 2025 | $0.26 | $0.30 | +13.8% | $3.33B | $3.17B | +5.3% |
| ▲ Q3 FY2025 | Aug 1, 2025 | $0.19 | $0.22 | +15.8% | $3.15B | $3.17B | -0.6% |
| ▲ Q2 FY2025 | May 2, 2025 | $0.08 | $0.19 | +137.5% | $2.88B | $2.90B | -0.9% |
| ▲ Q1 FY2025 | Mar 6, 2025 | $0.19 | $0.22 | +15.8% | $3.05B | $2.75B | +11.1% |
| ▼ Q4 FY2024 | Nov 1, 2024 | $0.18 | $0.11 | -38.9% | $2.91B | $2.94B | -1.1% |
Q3 FY2026
Jul 31, 2026
EPS Actual
—
EPS Est.
$0.35
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 1, 2026Beat
EPS Actual
$0.39
EPS Est.
$0.29
EPS Surpr.
+34.5%
Revenue
$3.61B
Q1 FY2026
Feb 27, 2026Miss
EPS Actual
$0.33
EPS Est.
$0.34
EPS Surpr.
-2.9%
Revenue
$3.55B
Q4 FY2025
Oct 31, 2025Beat
EPS Actual
$0.30
EPS Est.
$0.26
EPS Surpr.
+13.8%
Revenue
$3.33B
Q3 FY2025
Aug 1, 2025Beat
EPS Actual
$0.22
EPS Est.
$0.19
EPS Surpr.
+15.8%
Revenue
$3.15B
Q2 FY2025
May 2, 2025Beat
EPS Actual
$0.19
EPS Est.
$0.08
EPS Surpr.
+137.5%
Revenue
$2.88B
Q1 FY2025
Mar 6, 2025Beat
EPS Actual
$0.22
EPS Est.
$0.19
EPS Surpr.
+15.8%
Revenue
$3.05B
Q4 FY2024
Nov 1, 2024Miss
EPS Actual
$0.11
EPS Est.
$0.18
EPS Surpr.
-38.9%
Revenue
$2.91B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.72 | $0.74 | $0.75 | 7 |
| Q3 FY2028 | $0.66 | $0.67 | $0.68 | 4 |
| Q2 FY2028 | $0.59 | $0.60 | $0.61 | 6 |
| Q1 FY2028 | $0.56 | $0.57 | $0.58 | 4 |
| Q4 FY2027 | $0.58 | $0.59 | $0.60 | 6 |
| Q3 FY2027 | $0.52 | $0.53 | $0.54 | 3 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $5.1B | $5.2B | $5.3B | 3 |
| Q3 FY2028 | $4.9B | $4.9B | $5.0B | 5 |
| Q2 FY2028 | $4.7B | $4.8B | $4.8B | 3 |
| Q1 FY2028 | $4.6B | $4.7B | $4.8B | 3 |
| Q4 FY2027 | $4.5B | $4.5B | $4.6B | 4 |
| Q3 FY2027 | $4.3B | $4.3B | $4.4B | 5 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 1, 2026 | +34.5% | $47.97 | $52.58 | +9.61% |
| ▼ Q1 FY2026 | Feb 27, 2026 | -2.9% | $40.13 | $41.43 | +3.24% |
| ▲ Q4 FY2025 | Oct 31, 2025 | +13.8% | $32.79 | $33.05 | +0.79% |
| ▲ Q3 FY2025 | Aug 1, 2025 | +15.8% | $20.65 | $19.64 | -4.89% |
| ▲ Q2 FY2025 | May 2, 2025 | +137.5% | $17.90 | $20.87 | +16.59% |
| ▲ Q1 FY2025 | Mar 6, 2025 | +15.8% | $18.39 | $17.23 | -6.31% |
| ▼ Q4 FY2024 | Nov 1, 2024 | -38.9% | $14.97 | $17.25 | +15.23% |
| ▼ Q3 FY2024 | Aug 2, 2024 | -41.2% | $12.23 | $11.16 | -8.75% |
Q2 FY2026+9.61%
Report Date
May 1, 2026
EPS Beat/Miss
+34.5%
Price Before
$47.97
Price After
$52.58
Q1 FY2026+3.24%
Report Date
Feb 27, 2026
EPS Beat/Miss
-2.9%
Price Before
$40.13
Price After
$41.43
Q4 FY2025+0.79%
Report Date
Oct 31, 2025
EPS Beat/Miss
+13.8%
Price Before
$32.79
Price After
$33.05
Q3 FY2025-4.89%
Report Date
Aug 1, 2025
EPS Beat/Miss
+15.8%
Price Before
$20.65
Price After
$19.64
Q2 FY2025+16.59%
Report Date
May 2, 2025
EPS Beat/Miss
+137.5%
Price Before
$17.90
Price After
$20.87
Q1 FY2025-6.31%
Report Date
Mar 6, 2025
EPS Beat/Miss
+15.8%
Price Before
$18.39
Price After
$17.23
Q4 FY2024+15.23%
Report Date
Nov 1, 2024
EPS Beat/Miss
-38.9%
Price Before
$14.97
Price After
$17.25
Q3 FY2024-8.75%
Report Date
Aug 2, 2024
EPS Beat/Miss
-41.2%
Price Before
$12.23
Price After
$11.16
Avg Beat Reaction+3.16%
Avg Miss Reaction+3.24%
Beat Rate5 / 8 quarters
Largest Move+16.59% (Q2 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: BTSG ends December
BrightSpring Health Services, Inc. Common Stock (BTSG) most recently reported earnings on May 1, 2026 for Q2 FY2026, posting EPS of $0.39 — beating the analyst consensus of $0.29 by +34.5%. The next BTSG earnings date is expected around September 1, 2026.
Each quarter, investors track BTSG earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. BTSG revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
BTSG's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
BTSG earnings · 5 questionsBrightSpring Health Services, Inc. Common Stock's next earnings report is expected around September 1, 2026. BTSG typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; BTSG historically reports after market close (AMC).
BTSG earnings datewhen is BTSG earningsBTSG next earnings datewhen does BTSG report earningsBTSG earnings calendar
▸ Source: FMP · BrightSpring Health Services, Inc. Common Stock SEC filings · US GAAP · BrightSpring Health Services, Inc. Common Stock SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026